These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23297003)

  • 1. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.
    Jin H; Liang L; Liu L; Deng W; Liu J
    J Cell Biochem; 2013 Jul; 114(7):1498-509. PubMed ID: 23297003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
    Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylbutyrate sensitizes human glioblastoma cells lacking wild-type p53 function to ionizing radiation.
    Lopez CA; Feng FY; Herman JM; Nyati MK; Lawrence TS; Ljungman M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):214-20. PubMed ID: 17707275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
    Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
    Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 acetylation enhances Taxol-induced apoptosis in human cancer cells.
    Kim JH; Yoon EK; Chung HJ; Park SY; Hong KM; Lee CH; Lee YS; Choi K; Yang Y; Kim K; Kim IH
    Apoptosis; 2013 Jan; 18(1):110-20. PubMed ID: 23161364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
    Roy S; Packman K; Jeffrey R; Tenniswood M
    Cell Death Differ; 2005 May; 12(5):482-91. PubMed ID: 15746940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
    Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
    Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.
    Zhu WG; Lakshmanan RR; Beal MD; Otterson GA
    Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
    Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
    Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126.
    Sakamoto Y; Kato S; Takahashi M; Okada Y; Yasuda K; Watanabe G; Imai H; Sato A; Ishioka C
    Cancer Sci; 2011 Apr; 102(4):799-807. PubMed ID: 21214676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor.
    Fujii S; Okinaga T; Ariyoshi W; Takahashi O; Iwanaga K; Nishino N; Tominaga K; Nishihara T
    Biochem Biophys Res Commun; 2013 May; 434(3):413-20. PubMed ID: 23537658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage.
    Wang H; Zhou W; Zheng Z; Zhang P; Tu B; He Q; Zhu WG
    DNA Repair (Amst); 2012 Feb; 11(2):146-56. PubMed ID: 22112863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated and hypoacetylated mutant p53 enhances cisplatin-induced apoptosis through caspase-9 pathway in the absence of transcriptional activation or translation.
    Lai MD; Lin WC; Sun YM; Chang FL
    Int J Mol Med; 2005 Apr; 15(4):725-34. PubMed ID: 15754039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].
    Yu WJ; Wang L; You LS; Mei C; Ma QL; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):366-70. PubMed ID: 22781793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.